IMPEDIMED LIMITED — Capital/Financing Update 2008

Jul 10, 2008

==> picture [84 x 94] intentionally omitted <==

==> picture [57 x 10] intentionally omitted <==

----- Start of picture text ----- ASX : IPD----- End of picture text -----

11[th] July 2008

ASX ANNOUNCEMENT – SHARE PLACEMENT

ImpediMed Limited announces the conclusion of a share placement with two of its existing Institutional Investors effective today with the issue of 1,600,001 fully paid ordinary shares at 75 cents.

The $1,200,000 raised through the placement will be used by the company to accelerate activities targeted at developing the US market for the company’s devices used in the clinical assessment of Lymphoedema among patients who have had Breast Cancer.

The company acknowledges the support of ABN Amro and Lodge Partners in arranging the placement.

ImpediMed’s securities on issue following the issue of shares under the placement are summarised below.

==> picture [455 x 260] intentionally omitted <==

Phil Auckland Chief Financial Officer & Company Secretary